BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 1725537)

  • 1. Role of diltiazem in the treatment of silent myocardial ischemia.
    Waters D; Juneau M; Baird M; Klinke P; Warnica W; Chin C; Théroux P
    J Cardiovasc Pharmacol; 1991; 18 Suppl 9():S15-20. PubMed ID: 1725537
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Incremental doses of diltiazem in patients with coronary artery disease in end-stage renal failure maintained on hemodialysis: which is the optimal dose?].
    Cice G; Ferrara L; Tagliamonte E; Di Benedetto A; Iacono A
    Cardiologia; 1998 Dec; 43(12):1337-43. PubMed ID: 9988942
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Comparative effect of anti-anginal drugs on myocardial ischemia in patient with effort angina: evaluation by ambulatory electrocardiographic monitoring].
    Suzuki Y
    Hokkaido Igaku Zasshi; 1991 Jul; 66(4):441-9. PubMed ID: 1680782
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term management of exercise-induced myocardial ischemia. Diltiazem versus propranolol, a double-blind, crossover study.
    Romano M; di Maro T; Cotecchia MR; Carella G; de Arcangelis E; Clarizia M; Chiariello M
    Int J Clin Pharmacol Ther Toxicol; 1986 Oct; 24(10):551-4. PubMed ID: 3781675
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of hypertension associated with stable angina pectoris: favourable interaction between new metoprolol formulation (OROS) and nifedipine.
    Di Somma S; de Divitiis M; Bertocchi F; Carotenuto A; Cudemo G; Petitto M; Napodano M; de Divitiis O
    Cardiologia; 1996 Jul; 41(7):635-43. PubMed ID: 8831181
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of propranolol, diltiazem, and nifedipine in the treatment of ambulatory ischemia in patients with stable angina. Differential effects on ambulatory ischemia, exercise performance, and anginal symptoms. The ASIS Study Group.
    Stone PH; Gibson RS; Glasser SP; DeWood MA; Parker JD; Kawanishi DT; Crawford MH; Messineo FC; Shook TL; Raby K
    Circulation; 1990 Dec; 82(6):1962-72. PubMed ID: 2122926
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discordance of anti-ischemic and hemodynamic effects of captopril in stable coronary artery disease.
    Winkelmann BR; Matheis G; Kleist P; Pötter S; Wohltmann D; Kaltenbach M
    Coron Artery Dis; 1994 Oct; 5(10):829-44. PubMed ID: 7866603
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antianginal response to once-daily diltiazem CD in patients receiving concomitant beta-blockers, long-acting nitrates, or both. Diltiazem CD Study Group.
    Heller GV; Sridharan M; Morse J; Glasser S; Beach CL
    Pharmacotherapy; 1997; 17(4):760-6. PubMed ID: 9250554
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Silent myocardial ischemia in hypertensive patients].
    Un S; Mengden T; Glänzer K; Vetter H
    Praxis (Bern 1994); 2000 Apr; 89(18):757-64. PubMed ID: 10823014
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of low-dose aspirin and coronary vasodilators in acute unstable angina.
    Vejar M; Hackett D; Brunelli C; Spallarossa P; Ianetti M; Galassi AR; Lipkin D; Caponnetto S; Patrono C; Maseri A
    Circulation; 1990 Jan; 81(1 Suppl):I4-11; discussion I22-3. PubMed ID: 2403867
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Diltiazem in chronic stable angina].
    González-Hermosillo JA; Clemente AC; Salazar E
    Arch Inst Cardiol Mex; 1986; 56(4):327-32. PubMed ID: 2945527
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Diagnosis of silent ischemia in patients with previous myocardial infarct, under 45 years of age].
    Agoas R; Gomes V; Leiria G
    Rev Port Cardiol; 1990 Jun; 9(6):521-5. PubMed ID: 2248787
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Comparison of stress ECG and long-term ECG for detection of myocardial ischemia in patients with coronary heart disease].
    Osterhues HH; Eggeling T; Kochs M; Osterspey A; Hombach V
    Z Kardiol; 1994 Feb; 83(2):132-7. PubMed ID: 8165843
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of diltiazem slow-release formulation on silent myocardial ischemia in stable coronary artery disease. The Canadian Multicenter Diltiazem Study Group.
    Juneau M; Théroux P; Waters D
    Am J Cardiol; 1992 Mar; 69(7):30B-35B. PubMed ID: 1543140
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of free fatty acid inhibition on silent and symptomatic myocardial ischemia in diabetic patients with coronary artery disease.
    Marazzi G; Wajngarten M; Vitale C; Patrizi R; Pelliccia F; Gebara O; Pierri H; Ramires JA; Volterrani M; Fini M; Rosano GM
    Int J Cardiol; 2007 Aug; 120(1):79-84. PubMed ID: 17134770
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Value of Holter monitoring and the electrocardiographic exercise test in the diagnosis of silent ischemia after myocardial infarction].
    Dabrowski A; Piotrowicz R; Ostrowska B; Janczak J
    Kardiol Pol; 1989; 32(10-12):427-33. PubMed ID: 2638420
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical effects of calcium antagonists in silent ischemia.
    Pepine CJ
    J Cardiovasc Pharmacol; 1990; 16 Suppl 2():S9-12. PubMed ID: 1369708
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Subsets of ambulatory myocardial ischemia based on heart rate activity. Circadian distribution and response to anti-ischemic medication. The Angina and Silent Ischemia Study Group (ASIS).
    Andrews TC; Fenton T; Toyosaki N; Glasser SP; Young PM; MacCallum G; Gibson RS; Shook TL; Stone PH
    Circulation; 1993 Jul; 88(1):92-100. PubMed ID: 8319361
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of diltiazem on symptomatic and asymptomatic episodes of ST segment depression occurring during daily life and during exercise.
    Théroux P; Baird M; Juneau M; Warnica W; Klinke P; Kostuk W; Pflugfelder P; Lavallée E; Chin C; Dempsey E
    Circulation; 1991 Jul; 84(1):15-22. PubMed ID: 1905592
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sustained-release diltiazem reduces myocardial ischemic episodes in end-stage renal disease: a double-blind, randomized, crossover, placebo-controlled trial.
    Cice G; Di Benedetto A; D'Andrea A; D'Isa S; Ferrara L; Russo PE; Iacono A; Calabrò R
    J Am Soc Nephrol; 2003 Apr; 14(4):1006-11. PubMed ID: 12660335
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.